Eric Drape
Net Worth
Last updated:
What is Eric Drape net worth?
The estimated net worth of Mr. Eric Drape is at least $14,217,325 as of 5 Mar 2024. He owns shares worth $169,768 as insider, has earned $3,797,557 from insider trading and has received compensation worth at least $10,250,000 in Teva Pharmaceutical Industries Limited.
What is the salary of Eric Drape?
Mr. Eric Drape salary is $2,050,000 per year as Executive Vice President of Global Operations in Teva Pharmaceutical Industries Limited.
How old is Eric Drape?
Mr. Eric Drape is 63 years old, born in 1962.
What stocks does Eric Drape currently own?
As insider, Mr. Eric Drape owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | Executive Vice President of Global Operations | 9,701 | $17.5 | $169,768 |
What does Teva Pharmaceutical Industries Limited do?
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Eric Drape insider trading
Teva Pharmaceutical Industries Limited
Mr. Eric Drape has made 20 insider trades between 2020-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 173,261 units of TEVA stock on 16 Feb 2024. As of 5 Mar 2024 he still owns at least 9,701 units of TEVA stock.
Teva Pharmaceutical Industries Limited key executives
Teva Pharmaceutical Industries Limited executives and other stock owners filed with the SEC:
- Dr. Hafrun Fridriksdottir (63) Executive Vice President of Global R&D
- Mr. Eliyahu Sharon Kalif (52) Executive Vice President & Chief Financial Officer
- Mr. Eric Drape (63) Executive Vice President of Global Operations
- Mr. Kare Schultz (64) Pres, Chief Executive Officer & Director